CTLA4 and cancer: Secondly, as demonstrated by Llosa et al., neoplastic cells with MMR defect overexpress several immune checkpoint proteins (e.g., PD-1, PD-L1, CTLA-4, LAG-3, and IDO), compared to MSS cancers [88].